FIDFX | VEVYX | FIDFX / VEVYX | |
Total Expense Ratio | 0.75 | 0.66 | 114% |
Annual Report Gross Expense Ratio | 0.75 | 0.66 | 114% |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 3.729 | 3.103 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.75B | 17.2B | 10% |
Annual Yield % from dividends | 0.89 | 1.06 | 84% |
Returns for 1 year | -1.62 | -6.41 | 25% |
Returns for 3 years | 24.47 | 4.97 | 492% |
Returns for 5 years | 71.63 | 40.77 | 176% |
Returns for 10 years | N/A | 55.86 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SBI | 7.91 | 0.02 | +0.25% |
Western Asset Intermediate Muni Fund | |||
WCME | 16.84 | -0.04 | -0.26% |
First Trust WCM Devpg Wld Eq ETF | |||
CGBL | 34.78 | -0.13 | -0.37% |
Capital Group Core Balanced ETF | |||
HQL | 14.17 | -0.10 | -0.70% |
abrdn Life Sciences Investors | |||
QQQD | 13.95 | -0.22 | -1.55% |
Direxion Daily Concentrated Qs Bear 1X Shares |